The American Academy of Pediatrics is an organization of 66,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. The AAP is the largest pediatric publisher in the world, with a diverse list of resources that includes essential clinical and practice management titles and award-winning books for parents.Dennis C. Stokes, MD, MPH, FAAP was St. Jude Children’s Research Hospital Professor of Pediatrics (University of Tennessee Health Science Center) and Chief of the Division of Pediatric Pulmonology and Sleep Medicine at Le Bonheur Children’s Hospital and St. Jude Children’s Research Hospital in Memphis, Tennessee and Director of the Pediatric Pulmonology fellowship from 2007-16. He has been Cystic Fibrosis (CF) Center Director at the University of Tennessee/Le Bonheur Children’s Hospital, Children’s Hospital at Dartmouth, and Vanderbilt Monroe Carroll Children’s Hospital.Dr. Stokes is a graduate of Wabash College in Indiana and received his medical degree from the University of Kentucky. He completed his residency in Pediatrics at the Johns Hopkins Hospital and his pulmonary fellowship at Children’s Hospital Boston. His MPH in Epidemiology is from Indiana University. He is currently board certified in Pediatrics and Pediatric Pulmonology and previously board certified in Critical Care.Dr. Stokes has divided his career between patient care, teaching, and research. He has participated in multiple clinical trials in CF beginning in 1990 and was on the inaugural Advisory Board of the Epidemiologic Study of Cystic Fibrosis (ESCF). He has served as chair of the Publications and Presentations Committee of the CFF Therapeutic Development Network (TDN) and Chair of the Scientific Assembly on Pediatrics and Board Member of the American Thoracic Society, as well as the AAP Executive Committee on Pulmonology and Sleep Medicine. He was co-principal investigator for the CHAMP (Changing High Risk Asthma in Memphis Thru Partnership) CMS Innovation Award. His primary clinical and research interests have included cystic fibrosis, asthma, pulmonary infections in the immunocompromised host, and pulmonary complications of childhood cancer therapy.Allen J. Dozor, MD, FCCP, FAAP has been Chief of Pediatric Pulmonology, Allergy, Immunology, and Sleep Medicine at the Maria Fareri Children’s Hospital at Westchester Medical Center since 1985. He is Professor of Pediatrics and Clinical Public Health at New York Medical College. He is Director of the Armond V. Mascia, MD Cystic Fibrosis Center, and Associate Physician-In-Chief at the Maria Fareri Children’s Hospital. He is Program Director of the Fellowship in Pediatric Pulmonology, and Director of the Children’s Environmental Health Center of the Hudson Valley (www.childrensenvironment.org).Dr. Dozor is a graduate of the University of Pennsylvania and received his medical degree from Pennsylvania State University. He is board certified in Pediatrics and Pediatric Pulmonology. Dr. Dozor divides his time between patient care, teaching, and research. He has participated as a principal investigator or co-investigator in dozens of clinical trials and studies. His current areas of research include asthma, cystic fibrosis, and respiratory physiology, with a particular focus on environment and respiratory disease in children. He edited a textbook on pediatric pulmonology (Primary Pediatric Pulmonology, Blackwell Publishing) designed for primary care providers, and published a guidebook for families of children with asthma and allergies (The Asthma and Allergy Action Plan for Kids, Simon and Schuster). He has also focused for many years on quality improvement of asthma care by primary care providers.

“This is a useful, easy-to-read book that can be accessed during busy clinical days. Each topic includes a brief introduction, etiology and epidemiology, pathophysiology, clinical features, differential diagnosis, diagnostic considerations, and management.” — B. Louise Giles, MD, University of Chicago Pritzker School of Medicine

• Part I. Evaluation of Children With Respiratory Disease1. The Pediatric Pulmonary History2. The Pediatric Pulmonary Physical Examination3. Environmental History4. Office Pulmonary Function Testing for the Primary Care Provider5. Complete Pulmonary Function Tests6. Imaging7. Allergy Testing8. Bronchoscopy9. Oximetry and CapnographyPart II. Anatomic Disorders and Congenital Anomalies of the Airway, Lungs, Pulmonary Vessels, and Chest WallSection 1. Congenital Anomalies of the Airway10. Choanal Atresia11. Laryngomalacia12. Vocal Fold Paralysis13. Subglottic Stenosis14. Tracheomalacia, Vascular Rings and Slings, and Bronchomalacia15. Tracheoesophageal FistulasSection 2. Developmental Anomalies of the Lung and Pulmonary Vessels16. Pulmonary Hypoplasia17. Pulmonary Sequestration18. Congenital Lobar Emphysema and Overinflation19. Congenital Pulmonary Airway Malformation20. Bronchogenic Cysts21. Pulmonary Arteriovenous MalformationsSection 3. Structural Abnormalities of the Chest Wall22. Chest Wall Deformities: Thoracic Insufficiency Syndrome23. Pectus Deformities: Pectus Excavatum and Pectus Carinatum24. Spinal Deformities: Idiopathic Scoliosis and KyphoscoliosisPart III. Asthma and Related Conditions25. Diagnosis of Asthma26. Tobacco Smoke Exposure and Children27. Preventing and Treating Tobacco Dependence28. Complementary and Alternative Medicine Therapies for Asthma29. Allergic Rhinitis30. Asthma Guidelines: Overview31. Asthma Guidelines: Management of Acute Asthma32. Asthma Guidelines: Management of Chronic Asthma33. Pharmacologic Management: Short-acting Beta-Adrenergic Agonists34. Pharmacologic Management: Long-acting Beta-Adrenergic Agonists35. Pharmacologic Management: Inhaled Corticosteroids36. Pharmacologic Management: Leukotriene Receptor Agonists37. Pharmacologic Management: Anticholinergic Agents38. Pharmacologic Management: Systemic Corticosteroids39. Pharmacologic Management: Anti-Immunoglobulin E Therapy40. Immunotherapy41. Exercise-Induced Bronchoconstriction42. Recurrent Croup and Bronchitis43. Recurrent Wheezing in Infants, Toddlers, and Preschoolers44. Allergic Bronchopulmonary Aspergillosis in AsthmaPart IV. Infections of the Respiratory TractSection 1. Airway Infections45. Upper Respiratory Infections46. Laryngitis47. Epiglottitis48. Croup49. Papillomatosis50. Pertussis51. Bacterial Tracheitis52. Bronchitis53. BronchiolitisSection 2. Parenchymal Infections54. Bacterial Pneumonia55. Viral Pneumonia56. Mycoplasma Pneumonia57. Chlamydial Pneumonia58. Tuberculosis59. Nontuberculous Mycobacterial Pulmonary Disease60. Fungal Pneumonia61. Histoplasmosis and Other Endemic Fungal Pneumonias62. Complications of Pneumonia: Pleural Effusions63. Complications of Pneumonia: Empyema64. Complications of Pneumonia: Pulmonary Abscess65. Complications of Pneumonia: Postinfective Bronchiolitis ObliteransPart V. Genetic Respiratory Diseases66. Disorders of Surfactant Metabolism67. Cystic Fibrosis68. Cystic Fibrosis Newborn Screening69. CFTR-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis70. Primary Ciliary DyskinesiaPart VI. Miscellaneous Respiratory Diseases71. Bronchopulmonary Dysplasia72. Pneumothorax73. Pulmonary Aspiration: Foreign Bodies and Massive74. Gastroesophageal Reflux and Recurrent Small Volume Aspiration75. Hypersensitivity Pneumonitis76. Pulmonary Hemorrhage77. Pulmonary Hypertension78. Vocal Cord Dysfunction79. Tic Cough (Habit Cough)80. Smoke Inhalation81. Hydrocarbon Aspiration82. Drowning83. Thoracic Tumors84. Pulmonary Complications of Chemotherapy85. Children’s Diffuse and Interstitial Lung DiseasePart VII. Respiratory Disease in Association With Other Systemic Diseases86. Pulmonary Complications of Immune Deficiencies87. Sickle Cell Disease88. Respiratory Disease in Children With Congenital Heart Disease89. Respiratory Disease in Children After Cardiac Surgery90. Collagen Vascular-Related Lung Disease91. Vasculitis-Related Lung Disease92. Granulomatous Lung Disease93. Respiratory Disease Associated With Gastrointestinal and Hepatic Disease94. Pulmonary Complications of Cerebral Palsy and Neurodegenerative Diseases95. Pulmonary Complications of Neuromuscular Disease96. Respiratory Disease in Cancer SurvivorsPart VIII. Pediatric Sleep Medicine97. Brief, Resolved, Unexplained Events and Sudden Infant Death Syndrome98. Obstructive Sleep Apnea Syndrome99. Congenital Central Hypoventilation Syndrome100. Insomnias101. Excessive Somnolence102. Narcolepsy103. Parasomnias104. Sleep History and Sleep Hygiene105. Circadian Rhythm Disorders / Circadian Rhythm Sleep DisordersPart IX. Pediatric Respiratory Care106. Delivery of Inhaled Medications107. Small Volume Nebulizers108. Metered Dose Inhalers109. Dry Powdered Inhalers110. Spacers and Holding Chambers111. Inhaled Antibiotics112. Oxygen Therapy113. Tracheostomy Care and Complications114. Airway Clearance Devices and Techniques115. Continuous Positive Airway Pressure116. Bilevel Positive Airway Pressure117. Home Mechanical Ventilation118. Diaphragm Pacing by Phrenic Nerve Stimulation

The American Academy of Pediatrics is an organization of 66,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. The AAP is the largest pediatric publisher in the world, with a diverse list of resources that includes essential clinical and practice management titles and award-winning books for parents.Dennis C. Stokes, MD, MPH, FAAP was St. Jude Children’s Research Hospital Professor of Pediatrics (University of Tennessee Health Science Center) and Chief of the Division of Pediatric Pulmonology and Sleep Medicine at Le Bonheur Children’s Hospital and St. Jude Children’s Research Hospital in Memphis, Tennessee and Director of the Pediatric Pulmonology fellowship from 2007-16. He has been Cystic Fibrosis (CF) Center Director at the University of Tennessee/Le Bonheur Children’s Hospital, Children’s Hospital at Dartmouth, and Vanderbilt Monroe Carroll Children’s Hospital.Dr. Stokes is a graduate of Wabash College in Indiana and received his medical degree from the University of Kentucky. He completed his residency in Pediatrics at the Johns Hopkins Hospital and his pulmonary fellowship at Children’s Hospital Boston. His MPH in Epidemiology is from Indiana University. He is currently board certified in Pediatrics and Pediatric Pulmonology and previously board certified in Critical Care.Dr. Stokes has divided his career between patient care, teaching, and research. He has participated in multiple clinical trials in CF beginning in 1990 and was on the inaugural Advisory Board of the Epidemiologic Study of Cystic Fibrosis (ESCF). He has served as chair of the Publications and Presentations Committee of the CFF Therapeutic Development Network (TDN) and Chair of the Scientific Assembly on Pediatrics and Board Member of the American Thoracic Society, as well as the AAP Executive Committee on Pulmonology and Sleep Medicine. He was co-principal investigator for the CHAMP (Changing High Risk Asthma in Memphis Thru Partnership) CMS Innovation Award. His primary clinical and research interests have included cystic fibrosis, asthma, pulmonary infections in the immunocompromised host, and pulmonary complications of childhood cancer therapy.Allen J. Dozor, MD, FCCP, FAAP has been Chief of Pediatric Pulmonology, Allergy, Immunology, and Sleep Medicine at the Maria Fareri Children’s Hospital at Westchester Medical Center since 1985. He is Professor of Pediatrics and Clinical Public Health at New York Medical College. He is Director of the Armond V. Mascia, MD Cystic Fibrosis Center, and Associate Physician-In-Chief at the Maria Fareri Children’s Hospital. He is Program Director of the Fellowship in Pediatric Pulmonology, and Director of the Children’s Environmental Health Center of the Hudson Valley (www.childrensenvironment.org).Dr. Dozor is a graduate of the University of Pennsylvania and received his medical degree from Pennsylvania State University. He is board certified in Pediatrics and Pediatric Pulmonology. Dr. Dozor divides his time between patient care, teaching, and research. He has participated as a principal investigator or co-investigator in dozens of clinical trials and studies. His current areas of research include asthma, cystic fibrosis, and respiratory physiology, with a particular focus on environment and respiratory disease in children. He edited a textbook on pediatric pulmonology (Primary Pediatric Pulmonology, Blackwell Publishing) designed for primary care providers, and published a guidebook for families of children with asthma and allergies (The Asthma and Allergy Action Plan for Kids, Simon and Schuster). He has also focused for many years on quality improvement of asthma care by primary care providers.

“This is a useful, easy-to-read book that can be accessed during busy clinical days. Each topic includes a brief introduction, etiology and epidemiology, pathophysiology, clinical features, differential diagnosis, diagnostic considerations, and management.” — B. Louise Giles, MD, University of Chicago Pritzker School of Medicine

• Part I. Evaluation of Children With Respiratory Disease1. The Pediatric Pulmonary History2. The Pediatric Pulmonary Physical Examination3. Environmental History4. Office Pulmonary Function Testing for the Primary Care Provider5. Complete Pulmonary Function Tests6. Imaging7. Allergy Testing8. Bronchoscopy9. Oximetry and CapnographyPart II. Anatomic Disorders and Congenital Anomalies of the Airway, Lungs, Pulmonary Vessels, and Chest WallSection 1. Congenital Anomalies of the Airway10. Choanal Atresia11. Laryngomalacia12. Vocal Fold Paralysis13. Subglottic Stenosis14. Tracheomalacia, Vascular Rings and Slings, and Bronchomalacia15. Tracheoesophageal FistulasSection 2. Developmental Anomalies of the Lung and Pulmonary Vessels16. Pulmonary Hypoplasia17. Pulmonary Sequestration18. Congenital Lobar Emphysema and Overinflation19. Congenital Pulmonary Airway Malformation20. Bronchogenic Cysts21. Pulmonary Arteriovenous MalformationsSection 3. Structural Abnormalities of the Chest Wall22. Chest Wall Deformities: Thoracic Insufficiency Syndrome23. Pectus Deformities: Pectus Excavatum and Pectus Carinatum24. Spinal Deformities: Idiopathic Scoliosis and KyphoscoliosisPart III. Asthma and Related Conditions25. Diagnosis of Asthma26. Tobacco Smoke Exposure and Children27. Preventing and Treating Tobacco Dependence28. Complementary and Alternative Medicine Therapies for Asthma29. Allergic Rhinitis30. Asthma Guidelines: Overview31. Asthma Guidelines: Management of Acute Asthma32. Asthma Guidelines: Management of Chronic Asthma33. Pharmacologic Management: Short-acting Beta-Adrenergic Agonists34. Pharmacologic Management: Long-acting Beta-Adrenergic Agonists35. Pharmacologic Management: Inhaled Corticosteroids36. Pharmacologic Management: Leukotriene Receptor Agonists37. Pharmacologic Management: Anticholinergic Agents38. Pharmacologic Management: Systemic Corticosteroids39. Pharmacologic Management: Anti-Immunoglobulin E Therapy40. Immunotherapy41. Exercise-Induced Bronchoconstriction42. Recurrent Croup and Bronchitis43. Recurrent Wheezing in Infants, Toddlers, and Preschoolers44. Allergic Bronchopulmonary Aspergillosis in AsthmaPart IV. Infections of the Respiratory TractSection 1. Airway Infections45. Upper Respiratory Infections46. Laryngitis47. Epiglottitis48. Croup49. Papillomatosis50. Pertussis51. Bacterial Tracheitis52. Bronchitis53. BronchiolitisSection 2. Parenchymal Infections54. Bacterial Pneumonia55. Viral Pneumonia56. Mycoplasma Pneumonia57. Chlamydial Pneumonia58. Tuberculosis59. Nontuberculous Mycobacterial Pulmonary Disease60. Fungal Pneumonia61. Histoplasmosis and Other Endemic Fungal Pneumonias62. Complications of Pneumonia: Pleural Effusions63. Complications of Pneumonia: Empyema64. Complications of Pneumonia: Pulmonary Abscess65. Complications of Pneumonia: Postinfective Bronchiolitis ObliteransPart V. Genetic Respiratory Diseases66. Disorders of Surfactant Metabolism67. Cystic Fibrosis68. Cystic Fibrosis Newborn Screening69. CFTR-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis70. Primary Ciliary DyskinesiaPart VI. Miscellaneous Respiratory Diseases71. Bronchopulmonary Dysplasia72. Pneumothorax73. Pulmonary Aspiration: Foreign Bodies and Massive74. Gastroesophageal Reflux and Recurrent Small Volume Aspiration75. Hypersensitivity Pneumonitis76. Pulmonary Hemorrhage77. Pulmonary Hypertension78. Vocal Cord Dysfunction79. Tic Cough (Habit Cough)80. Smoke Inhalation81. Hydrocarbon Aspiration82. Drowning83. Thoracic Tumors84. Pulmonary Complications of Chemotherapy85. Children’s Diffuse and Interstitial Lung DiseasePart VII. Respiratory Disease in Association With Other Systemic Diseases86. Pulmonary Complications of Immune Deficiencies87. Sickle Cell Disease88. Respiratory Disease in Children With Congenital Heart Disease89. Respiratory Disease in Children After Cardiac Surgery90. Collagen Vascular-Related Lung Disease91. Vasculitis-Related Lung Disease92. Granulomatous Lung Disease93. Respiratory Disease Associated With Gastrointestinal and Hepatic Disease94. Pulmonary Complications of Cerebral Palsy and Neurodegenerative Diseases95. Pulmonary Complications of Neuromuscular Disease96. Respiratory Disease in Cancer SurvivorsPart VIII. Pediatric Sleep Medicine97. Brief, Resolved, Unexplained Events and Sudden Infant Death Syndrome98. Obstructive Sleep Apnea Syndrome99. Congenital Central Hypoventilation Syndrome100. Insomnias101. Excessive Somnolence102. Narcolepsy103. Parasomnias104. Sleep History and Sleep Hygiene105. Circadian Rhythm Disorders / Circadian Rhythm Sleep DisordersPart IX. Pediatric Respiratory Care106. Delivery of Inhaled Medications107. Small Volume Nebulizers108. Metered Dose Inhalers109. Dry Powdered Inhalers110. Spacers and Holding Chambers111. Inhaled Antibiotics112. Oxygen Therapy113. Tracheostomy Care and Complications114. Airway Clearance Devices and Techniques115. Continuous Positive Airway Pressure116. Bilevel Positive Airway Pressure117. Home Mechanical Ventilation118. Diaphragm Pacing by Phrenic Nerve Stimulation

The American Academy of Pediatrics is an organization of 66,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. The AAP is the largest pediatric publisher in the world, with a diverse list of resources that includes essential clinical and practice management titles and award-winning books for parents.Dennis C. Stokes, MD, MPH, FAAP was St. Jude Children’s Research Hospital Professor of Pediatrics (University of Tennessee Health Science Center) and Chief of the Division of Pediatric Pulmonology and Sleep Medicine at Le Bonheur Children’s Hospital and St. Jude Children’s Research Hospital in Memphis, Tennessee and Director of the Pediatric Pulmonology fellowship from 2007-16. He has been Cystic Fibrosis (CF) Center Director at the University of Tennessee/Le Bonheur Children’s Hospital, Children’s Hospital at Dartmouth, and Vanderbilt Monroe Carroll Children’s Hospital.Dr. Stokes is a graduate of Wabash College in Indiana and received his medical degree from the University of Kentucky. He completed his residency in Pediatrics at the Johns Hopkins Hospital and his pulmonary fellowship at Children’s Hospital Boston. His MPH in Epidemiology is from Indiana University. He is currently board certified in Pediatrics and Pediatric Pulmonology and previously board certified in Critical Care.Dr. Stokes has divided his career between patient care, teaching, and research. He has participated in multiple clinical trials in CF beginning in 1990 and was on the inaugural Advisory Board of the Epidemiologic Study of Cystic Fibrosis (ESCF). He has served as chair of the Publications and Presentations Committee of the CFF Therapeutic Development Network (TDN) and Chair of the Scientific Assembly on Pediatrics and Board Member of the American Thoracic Society, as well as the AAP Executive Committee on Pulmonology and Sleep Medicine. He was co-principal investigator for the CHAMP (Changing High Risk Asthma in Memphis Thru Partnership) CMS Innovation Award. His primary clinical and research interests have included cystic fibrosis, asthma, pulmonary infections in the immunocompromised host, and pulmonary complications of childhood cancer therapy.Allen J. Dozor, MD, FCCP, FAAP has been Chief of Pediatric Pulmonology, Allergy, Immunology, and Sleep Medicine at the Maria Fareri Children’s Hospital at Westchester Medical Center since 1985. He is Professor of Pediatrics and Clinical Public Health at New York Medical College. He is Director of the Armond V. Mascia, MD Cystic Fibrosis Center, and Associate Physician-In-Chief at the Maria Fareri Children’s Hospital. He is Program Director of the Fellowship in Pediatric Pulmonology, and Director of the Children’s Environmental Health Center of the Hudson Valley (www.childrensenvironment.org).Dr. Dozor is a graduate of the University of Pennsylvania and received his medical degree from Pennsylvania State University. He is board certified in Pediatrics and Pediatric Pulmonology. Dr. Dozor divides his time between patient care, teaching, and research. He has participated as a principal investigator or co-investigator in dozens of clinical trials and studies. His current areas of research include asthma, cystic fibrosis, and respiratory physiology, with a particular focus on environment and respiratory disease in children. He edited a textbook on pediatric pulmonology (Primary Pediatric Pulmonology, Blackwell Publishing) designed for primary care providers, and published a guidebook for families of children with asthma and allergies (The Asthma and Allergy Action Plan for Kids, Simon and Schuster). He has also focused for many years on quality improvement of asthma care by primary care providers.

“This is a useful, easy-to-read book that can be accessed during busy clinical days. Each topic includes a brief introduction, etiology and epidemiology, pathophysiology, clinical features, differential diagnosis, diagnostic considerations, and management.” — B. Louise Giles, MD, University of Chicago Pritzker School of Medicine

• Part I. Evaluation of Children With Respiratory Disease1. The Pediatric Pulmonary History2. The Pediatric Pulmonary Physical Examination3. Environmental History4. Office Pulmonary Function Testing for the Primary Care Provider5. Complete Pulmonary Function Tests6. Imaging7. Allergy Testing8. Bronchoscopy9. Oximetry and CapnographyPart II. Anatomic Disorders and Congenital Anomalies of the Airway, Lungs, Pulmonary Vessels, and Chest WallSection 1. Congenital Anomalies of the Airway10. Choanal Atresia11. Laryngomalacia12. Vocal Fold Paralysis13. Subglottic Stenosis14. Tracheomalacia, Vascular Rings and Slings, and Bronchomalacia15. Tracheoesophageal FistulasSection 2. Developmental Anomalies of the Lung and Pulmonary Vessels16. Pulmonary Hypoplasia17. Pulmonary Sequestration18. Congenital Lobar Emphysema and Overinflation19. Congenital Pulmonary Airway Malformation20. Bronchogenic Cysts21. Pulmonary Arteriovenous MalformationsSection 3. Structural Abnormalities of the Chest Wall22. Chest Wall Deformities: Thoracic Insufficiency Syndrome23. Pectus Deformities: Pectus Excavatum and Pectus Carinatum24. Spinal Deformities: Idiopathic Scoliosis and KyphoscoliosisPart III. Asthma and Related Conditions25. Diagnosis of Asthma26. Tobacco Smoke Exposure and Children27. Preventing and Treating Tobacco Dependence28. Complementary and Alternative Medicine Therapies for Asthma29. Allergic Rhinitis30. Asthma Guidelines: Overview31. Asthma Guidelines: Management of Acute Asthma32. Asthma Guidelines: Management of Chronic Asthma33. Pharmacologic Management: Short-acting Beta-Adrenergic Agonists34. Pharmacologic Management: Long-acting Beta-Adrenergic Agonists35. Pharmacologic Management: Inhaled Corticosteroids36. Pharmacologic Management: Leukotriene Receptor Agonists37. Pharmacologic Management: Anticholinergic Agents38. Pharmacologic Management: Systemic Corticosteroids39. Pharmacologic Management: Anti-Immunoglobulin E Therapy40. Immunotherapy41. Exercise-Induced Bronchoconstriction42. Recurrent Croup and Bronchitis43. Recurrent Wheezing in Infants, Toddlers, and Preschoolers44. Allergic Bronchopulmonary Aspergillosis in AsthmaPart IV. Infections of the Respiratory TractSection 1. Airway Infections45. Upper Respiratory Infections46. Laryngitis47. Epiglottitis48. Croup49. Papillomatosis50. Pertussis51. Bacterial Tracheitis52. Bronchitis53. BronchiolitisSection 2. Parenchymal Infections54. Bacterial Pneumonia55. Viral Pneumonia56. Mycoplasma Pneumonia57. Chlamydial Pneumonia58. Tuberculosis59. Nontuberculous Mycobacterial Pulmonary Disease60. Fungal Pneumonia61. Histoplasmosis and Other Endemic Fungal Pneumonias62. Complications of Pneumonia: Pleural Effusions63. Complications of Pneumonia: Empyema64. Complications of Pneumonia: Pulmonary Abscess65. Complications of Pneumonia: Postinfective Bronchiolitis ObliteransPart V. Genetic Respiratory Diseases66. Disorders of Surfactant Metabolism67. Cystic Fibrosis68. Cystic Fibrosis Newborn Screening69. CFTR-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis70. Primary Ciliary DyskinesiaPart VI. Miscellaneous Respiratory Diseases71. Bronchopulmonary Dysplasia72. Pneumothorax73. Pulmonary Aspiration: Foreign Bodies and Massive74. Gastroesophageal Reflux and Recurrent Small Volume Aspiration75. Hypersensitivity Pneumonitis76. Pulmonary Hemorrhage77. Pulmonary Hypertension78. Vocal Cord Dysfunction79. Tic Cough (Habit Cough)80. Smoke Inhalation81. Hydrocarbon Aspiration82. Drowning83. Thoracic Tumors84. Pulmonary Complications of Chemotherapy85. Children’s Diffuse and Interstitial Lung DiseasePart VII. Respiratory Disease in Association With Other Systemic Diseases86. Pulmonary Complications of Immune Deficiencies87. Sickle Cell Disease88. Respiratory Disease in Children With Congenital Heart Disease89. Respiratory Disease in Children After Cardiac Surgery90. Collagen Vascular-Related Lung Disease91. Vasculitis-Related Lung Disease92. Granulomatous Lung Disease93. Respiratory Disease Associated With Gastrointestinal and Hepatic Disease94. Pulmonary Complications of Cerebral Palsy and Neurodegenerative Diseases95. Pulmonary Complications of Neuromuscular Disease96. Respiratory Disease in Cancer SurvivorsPart VIII. Pediatric Sleep Medicine97. Brief, Resolved, Unexplained Events and Sudden Infant Death Syndrome98. Obstructive Sleep Apnea Syndrome99. Congenital Central Hypoventilation Syndrome100. Insomnias101. Excessive Somnolence102. Narcolepsy103. Parasomnias104. Sleep History and Sleep Hygiene105. Circadian Rhythm Disorders / Circadian Rhythm Sleep DisordersPart IX. Pediatric Respiratory Care106. Delivery of Inhaled Medications107. Small Volume Nebulizers108. Metered Dose Inhalers109. Dry Powdered Inhalers110. Spacers and Holding Chambers111. Inhaled Antibiotics112. Oxygen Therapy113. Tracheostomy Care and Complications114. Airway Clearance Devices and Techniques115. Continuous Positive Airway Pressure116. Bilevel Positive Airway Pressure117. Home Mechanical Ventilation118. Diaphragm Pacing by Phrenic Nerve Stimulation